Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Hematopoietic growth factors: general presentation]

J J Guillosson1

  • 1Laboratoire d'Hématologie Cellulaire et Moléculaire, Pharmaceutiques et Biologiques de Paris V, Paris.

Annales Pharmaceutiques Francaises
|January 1, 1996
PubMed
Summary

Modern molecular haematology utilizes hematopoietic growth factors (HGFs) for cell survival and proliferation. While recombinant HGFs offer therapeutic promise, their significant costs and potential risks require careful evaluation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effect of retinoic acid on the proliferation and tumorigenicity of mouse mastocytoma cells : Effect of retinoic acid on mastocytoma cells.

Cytotechnology·2012
Same author

Mast cells as a source and target for nitric oxide.

International immunopharmacology·2001
Same author

[Recommendations for setting up and using point of care blood gas systems].

Annales de biologie clinique·2001
Same author

Autocrine regulation of cord blood-derived human mast cell activation by IL-10.

The Journal of allergy and clinical immunology·2001
Same author

Role of iron in tumor cell protection from the pro-apoptotic effect of nitric oxide.

Cancer research·2001
Same author

Inhibition of IgE-induced activation of human mast cells by IL-10.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2001

Area of Science:

  • Molecular Haematology
  • Cytokine Biology
  • Genetic Engineering

Context:

  • Hematopoietic growth factors (HGFs) are crucial cytokines regulating blood cell development.
  • Advances in understanding HGF structure, receptors, and genes enable recombinant production.
  • Recombinant human growth factors hold significant therapeutic potential in clinical haematology.

Purpose:

  • To review the advancements in molecular haematology concerning hematopoietic growth factors (HGFs).
  • To discuss the therapeutic potential and inherent risks associated with HGFs.
  • To highlight the need for evaluating the costs and benefits of HGF therapy.

Summary:

  • Hematopoietic growth factors (HGFs) are key cytokines essential for hematopoietic cell survival, proliferation, and differentiation.

Related Experiment Videos

  • Genetic engineering allows for the production of recombinant human growth factors, offering therapeutic hope.
  • The use of HGFs, despite their cost, presents a double-edged sword due to potential off-target effects and requires risk-benefit assessment.

    • Impact:

    • Provides a comprehensive overview of HGFs in molecular haematology.
    • Emphasizes the dual nature of HGFs as both therapeutic agents and potential risks.
    • Underscores the importance of ongoing evaluation of HGF therapy costs and safety profiles.